Biggest News Aggregation in the World
📰 Fire Capital News

Page 2 - Fire Capital News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Fire Capital. Real-time updates on events, politics, business and more.

Brokerages Set Larimar Therapeutics, Inc. (NASDAQ:LRMR) Price Target at $21.33

Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) has earned a consensus recommendation of “Buy” from the six analysts that are covering the company, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last […]
Leerink Partnrs Larimar Therapeutics Inc Sg Americas Securities Fred Alger Management Entrypoint Capital Virtu Financial

Iovance Biotherapeutics (NASDAQ:IOVA) Receives "Buy" Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of Iovance Biotherapeutics (NASDAQ:IOVA – Free Report) in a research report sent to investors on Friday, Benzinga reports. HC Wainwright currently has a $32.00 price target on the biotechnology company’s stock. A number of other research analysts have also weighed in on IOVA. The Goldman Sachs Group […]
United States Piper Sandler Iovance Biotherapeutics Iovance Biotherapeutics Inc Wells Fargo Company Raymond James Associates
Source: wkrb13.com

Cadeler A/S (NYSE:CDLR) Reaches New 12-Month High at $24.21

Cadeler A/S (NYSE:CDLR – Get Free Report)’s stock price reached a new 52-week high during trading on Tuesday . The stock traded as high as $24.21 and last traded at $23.52, with a volume of 50359 shares trading hands. The stock had previously closed at $23.66. Cadeler A/S Price Performance The firm’s 50-day moving average […]
Privium Fund Management United Kingdom Ltd Tt International Asset Management Securities Inc Get Free Report Fund Management United Kingdom Ltd Fire Capital

IGM Biosciences (NASDAQ:IGMS) Stock Price Down 4.7%

Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) fell 4.7% during trading on Tuesday . The stock traded as low as $8.98 and last traded at $9.10. 88,139 shares changed hands during trading, a decline of 72% from the average session volume of 310,274 shares. The stock had previously closed at $9.55. Wall […]
British Columbia Fred Schwarzer Dekabank Deutsche Girozentrale Biosciences Inc Nisa Investment Advisors Royal Bank
Source: wkrb13.com

JMP Securities Cuts BioAtla (NASDAQ:BCAB) Price Target to $5.00

BioAtla (NASDAQ:BCAB – Free Report) had its target price cut by JMP Securities from $12.00 to $5.00 in a research report sent to investors on Thursday morning, Benzinga reports. They currently have a market outperform rating on the stock. Separately, HC Wainwright restated a buy rating and issued a $7.00 target price on shares of […]
Bioatla Inc Panagora Asset Management Inc Pricet Rowe Associates Inc Asset Management Corp Virtu Financial Free Report

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

StockNews.com Initiates Coverage on Creative Media & Community Trust Co. (NASDAQ:CMCT)

StockNews.com began coverage on shares of Creative Media & Community Trust Co. (NASDAQ:CMCT – Free Report) in a report released on Thursday morning. The brokerage issued a sell rating on the real estate investment trust’s stock. Separately, B. Riley assumed coverage on shares of Creative Media & Community Trust Co. in a report on Thursday, […]
United States Creative Media Community Trust Corporation The Company Creative Media Community Trust Co Victory Capital Management Inc First Foundation Advisors Company Profile

BioAtla (NASDAQ:BCAB) Price Target Lowered to $5.00 at JMP Securities

BioAtla (NASDAQ:BCAB – Free Report) had its price target cut by JMP Securities from $12.00 to $5.00 in a report issued on Thursday, Benzinga reports. They currently have a market outperform rating on the stock. Separately, HC Wainwright restated a buy rating and issued a $7.00 price target on shares of BioAtla in a research […]
Panagora Asset Management Inc Formidable Asset Management Bioatla Inc Bioatla Company Profile Sectoral Asset Management Inc Perceptive Advisors
Source: wkrb13.com

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $14.94 Consensus PT from Brokerages

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month price objective […]
Affinity Asset Advisors Terns Pharmaceuticals Terns Pharmaceuticals Price Performance Analyst Recommendations For Terns Pharmaceuticals Terns Pharmaceuticals Company Profile Vivo Opportunity Llc

StockNews.com Begins Coverage on Creative Media & Community Trust Co. (NASDAQ:CMCT)

StockNews.com started coverage on shares of Creative Media & Community Trust Co. (NASDAQ:CMCT – Free Report) in a research note released on Thursday morning. The firm issued a sell rating on the real estate investment trust’s stock. Separately, B. Riley started coverage on shares of Creative Media & Community Trust Co. in a research note […]
United States Creative Media Community Trust Corporation The Company Company Profile Victory Capital Management Inc First Foundation Advisors Creative Media Community Trust Co

Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) Price Target at $27.94

Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month price […]
Teresa Brophy Bair Sg Americas Securities Fund Management Co Kura Oncology Company Profile E Fund Management Co Securities Exchange Commission

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science